PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,120,117 | +262.1% | 102,823 | +248.9% | 0.04% | +288.9% |
| Q4 2022 | $1,137,914 | -38.3% | 29,472 | -15.0% | 0.01% | -40.0% |
| Q3 2022 | $1,845,000 | -16.2% | 34,685 | -8.2% | 0.02% | -28.6% |
| Q2 2022 | $2,202,000 | -66.9% | 37,767 | -68.3% | 0.02% | -69.6% |
| Q3 2021 | $6,662,000 | +62.4% | 118,970 | +76.0% | 0.07% | +56.8% |
| Q2 2021 | $4,101,000 | +128.9% | 67,589 | +164.4% | 0.04% | +100.0% |
| Q1 2021 | $1,792,000 | +127.4% | 25,563 | +95.1% | 0.02% | +46.7% |
| Q3 2020 | $788,000 | +114.1% | 13,100 | +19.4% | 0.02% | -34.8% |
| Q1 2020 | $368,000 | -88.2% | 10,967 | -86.7% | 0.02% | -75.0% |
| Q3 2019 | $3,130,000 | +3.4% | 82,200 | +18.1% | 0.09% | -14.0% |
| Q2 2019 | $3,027,000 | +33.9% | 69,600 | +17.2% | 0.11% | +35.4% |
| Q1 2019 | $2,261,000 | -46.9% | 59,400 | -40.0% | 0.08% | -51.8% |
| Q4 2018 | $4,259,000 | +145.3% | 99,011 | +77.7% | 0.16% | +26.2% |
| Q1 2018 | $1,736,000 | +511.3% | 55,731 | +834.8% | 0.13% | +348.3% |
| Q2 2017 | $284,000 | -51.5% | 5,962 | -53.5% | 0.03% | -50.8% |
| Q1 2017 | $585,000 | -57.1% | 12,826 | -68.3% | 0.06% | -80.7% |
| Q2 2016 | $1,364,000 | – | 40,447 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |